BENDAZAC
UNII G4AG71204O

Substance Identification & Data

This profile provides standardized clinical and technical data for Bendazac, uniquely identified by the FDA Unique Ingredient Identifier (UNII) G4AG71204O.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 20187-55-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

G4AG71204O

CAS Registry Number

20187-55-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BENDAZAC

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C16H14N2O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BYFMCKSPFYVMOU-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C80537

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

2313

Unique identification number in the NCBI database of chemical substances.

INN ID

2654

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1(nc(OCC(=O)O)c2c1cccc2)Cc3ccccc3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bendazac. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.